| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF451 ZNF641 SNAI2 ZBTB40 NFXL1 ZFHX2 TSHZ1 ZNF98 ZNF714 | 2.60e-09 | 1412 | 98 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF597 SP4 ZNF492 ZNF142 ZFAT ZNF658 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF641 SNAI2 NFXL1 ZFHX2 ZNF98 ZNF714 | 6.49e-06 | 1459 | 98 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF597 SP4 ZNF492 ZFAT ZNF658 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 SNAI2 ZFHX2 ZNF98 ZNF714 | 3.11e-05 | 1244 | 98 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF597 SP4 ZNF492 ZFAT ZNF658 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 SNAI2 ZFHX2 ZNF98 ZNF714 | 4.12e-05 | 1271 | 98 | 18 | GO:0000987 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF804A ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 TSHZ1 ZNF98 ZNF714 | 1.52e-16 | 775 | 97 | 28 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF804A ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 TSHZ1 ZNF98 ZNF714 | 1.62e-16 | 777 | 97 | 28 | PS00028 |
| Domain | Znf_C2H2-like | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF804A ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 TSHZ1 ZNF98 ZNF714 | 3.01e-16 | 796 | 97 | 28 | IPR015880 |
| Domain | Znf_C2H2 | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF804A ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 TSHZ1 ZNF98 ZNF714 | 4.01e-16 | 805 | 97 | 28 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF804A ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 TSHZ1 ZNF98 ZNF714 | 4.41e-16 | 808 | 97 | 28 | SM00355 |
| Domain | zf-C2H2 | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 ZNF98 ZNF714 | 9.17e-15 | 693 | 97 | 25 | PF00096 |
| Domain | - | ZNF597 SP4 ZNF492 ZNF142 ZFAT ZNF658 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 ZNF98 ZNF714 | 4.84e-13 | 679 | 97 | 23 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF597 SP4 ZNF492 ZNF142 ZFAT ZNF658 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 ZNF98 ZNF714 | 7.61e-13 | 694 | 97 | 23 | IPR013087 |
| Domain | zf-C2H2_6 | ZNF597 ZNF492 ZNF658 ZNF423 ZNF521 E4F1 ZNF236 ZNF260 ZNF117 ZNF532 ZFP64 SNAI2 ZNF98 ZNF714 | 8.62e-10 | 314 | 97 | 14 | PF13912 |
| Domain | Teashirt_fam | 1.36e-07 | 3 | 97 | 3 | IPR027008 | |
| Domain | DEK_C | 1.59e-04 | 4 | 97 | 2 | IPR014876 | |
| Domain | Neurofascin/L1/NrCAM_C | 1.59e-04 | 4 | 97 | 2 | IPR026966 | |
| Domain | Bravo_FIGEY | 1.59e-04 | 4 | 97 | 2 | PF13882 | |
| Domain | DEK_C | 1.59e-04 | 4 | 97 | 2 | PF08766 | |
| Domain | DAPIN | 1.95e-04 | 22 | 97 | 3 | PS50824 | |
| Domain | PYRIN | 1.95e-04 | 22 | 97 | 3 | PF02758 | |
| Domain | DAPIN | 1.95e-04 | 22 | 97 | 3 | IPR004020 | |
| Domain | PYRIN | 1.95e-04 | 22 | 97 | 3 | SM01289 | |
| Domain | C1_1 | 2.19e-04 | 57 | 97 | 4 | PF00130 | |
| Domain | NACHT | 2.23e-04 | 23 | 97 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 2.23e-04 | 23 | 97 | 3 | IPR007111 | |
| Domain | C2H2_Znf_fam | 2.54e-04 | 24 | 97 | 3 | IPR027775 | |
| Domain | DUF3504 | 2.64e-04 | 5 | 97 | 2 | IPR021893 | |
| Domain | DUF3504 | 2.64e-04 | 5 | 97 | 2 | PF12012 | |
| Domain | ZF_DAG_PE_1 | 3.42e-04 | 64 | 97 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.42e-04 | 64 | 97 | 4 | PS50081 | |
| Domain | C1 | 3.63e-04 | 65 | 97 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 3.85e-04 | 66 | 97 | 4 | IPR002219 | |
| Domain | USP_1 | 4.82e-04 | 70 | 97 | 4 | PS00972 | |
| Domain | UCH | 5.09e-04 | 71 | 97 | 4 | PF00443 | |
| Domain | USP_2 | 5.09e-04 | 71 | 97 | 4 | PS00973 | |
| Domain | USP_3 | 5.37e-04 | 72 | 97 | 4 | PS50235 | |
| Domain | USP_dom | 5.37e-04 | 72 | 97 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 5.37e-04 | 72 | 97 | 4 | IPR001394 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 5.51e-04 | 7 | 97 | 2 | IPR003529 | |
| Domain | Znf_MYM | 5.51e-04 | 7 | 97 | 2 | IPR010507 | |
| Domain | zf-FCS | 5.51e-04 | 7 | 97 | 2 | PF06467 | |
| Domain | KRAB | 5.53e-04 | 358 | 97 | 8 | PS50805 | |
| Domain | KRAB | 6.86e-04 | 370 | 97 | 8 | IPR001909 | |
| Domain | TRASH_dom | 7.32e-04 | 8 | 97 | 2 | IPR011017 | |
| Domain | TRASH | 7.32e-04 | 8 | 97 | 2 | SM00746 | |
| Domain | HEMATOPO_REC_L_F2 | 7.32e-04 | 8 | 97 | 2 | PS01353 | |
| Domain | LRR_6 | 2.93e-03 | 55 | 97 | 3 | PF13516 | |
| Domain | KRAB | 3.11e-03 | 369 | 97 | 7 | SM00349 | |
| Domain | Zinc_finger_PHD-type_CS | 4.70e-03 | 65 | 97 | 3 | IPR019786 | |
| Domain | USP_CS | 4.90e-03 | 66 | 97 | 3 | IPR018200 | |
| Domain | LIM | 5.55e-03 | 69 | 97 | 3 | PF00412 | |
| Domain | - | 5.78e-03 | 70 | 97 | 3 | 2.10.110.10 | |
| Domain | Znf_LIM | 6.01e-03 | 71 | 97 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 6.01e-03 | 71 | 97 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 6.01e-03 | 71 | 97 | 3 | PS50023 | |
| Domain | LIM | 6.01e-03 | 71 | 97 | 3 | SM00132 | |
| Domain | PWWP | 6.29e-03 | 23 | 97 | 2 | PF00855 | |
| Domain | PWWP_dom | 6.29e-03 | 23 | 97 | 2 | IPR000313 | |
| Domain | PWWP | 6.84e-03 | 24 | 97 | 2 | PS50812 | |
| Domain | Homeodomain-like | 7.70e-03 | 332 | 97 | 6 | IPR009057 | |
| Domain | - | 8.90e-03 | 449 | 97 | 7 | 3.30.40.10 | |
| Pubmed | Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development. | 2.31e-08 | 3 | 100 | 3 | 16631416 | |
| Pubmed | Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction. | 2.31e-08 | 3 | 100 | 3 | 19745106 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 14973285 | ||
| Pubmed | 3.74e-07 | 418 | 100 | 10 | 34709266 | ||
| Pubmed | FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. | 8.01e-07 | 7 | 100 | 3 | 19343227 | |
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 12019269 | ||
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 15834955 | ||
| Pubmed | SIN3B ZNF521 E4F1 BIRC6 RING1 ZIC4 ZNF532 ZFP64 SNAI2 ZFHX2 ZMYM3 | 6.40e-06 | 709 | 100 | 11 | 22988430 | |
| Pubmed | DOCK11 and DENND2A play pivotal roles in the maintenance of hepatitis B virus in host cells. | 8.18e-06 | 2 | 100 | 2 | 33539396 | |
| Pubmed | Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. | 8.18e-06 | 2 | 100 | 2 | 15734731 | |
| Pubmed | Expression and regulation of mouse Mtsh1 during limb and branchial arch development. | 8.18e-06 | 2 | 100 | 2 | 11668608 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21423795 | ||
| Pubmed | Vertebrate orthologues of the Drosophila region-specific patterning gene teashirt. | 8.18e-06 | 2 | 100 | 2 | 10704881 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18588951 | ||
| Pubmed | Novel families of toxin-like peptides in insects and mammals: a computational approach. | 8.18e-06 | 2 | 100 | 2 | 17433819 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12393497 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 20403135 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 12563287 | ||
| Pubmed | 8.39e-06 | 95 | 100 | 5 | 20843830 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF597 ZMYM2 ZNF202 E4F1 ZNF236 ZSCAN32 BRCA2 ZNF451 ZFP64 ZNF641 ZNF714 FHL5 | 8.44e-06 | 877 | 100 | 12 | 20211142 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP4 TSHZ3 TSHZ2 ZNF202 E4F1 ZNF236 ZNF451 SNAI2 NFXL1 ZFHX2 TSHZ1 THAP12 | 1.19e-05 | 908 | 100 | 12 | 19274049 |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 24891617 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 2.45e-05 | 3 | 100 | 2 | 26788497 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 16924233 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 14531860 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 37042466 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 18447583 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19527720 | ||
| Pubmed | Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. | 2.45e-05 | 3 | 100 | 2 | 15314180 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 37342906 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26683461 | ||
| Pubmed | Involvement of the prostate and testis expression (PATE)-like proteins in sperm-oocyte interaction. | 2.45e-05 | 3 | 100 | 2 | 22402205 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.53e-05 | 430 | 100 | 8 | 35044719 | |
| Pubmed | The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia. | 4.89e-05 | 4 | 100 | 2 | 29618029 | |
| Pubmed | Structural and functional evolution of the L1 family: are four adhesion molecules better than one? | 4.89e-05 | 4 | 100 | 2 | 10662501 | |
| Pubmed | An essential role of N-terminal arginylation in cardiovascular development. | 4.89e-05 | 4 | 100 | 2 | 12098698 | |
| Pubmed | Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. | 4.89e-05 | 4 | 100 | 2 | 25814692 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 17848544 | ||
| Pubmed | BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1. | 4.89e-05 | 4 | 100 | 2 | 25733871 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 31987042 | ||
| Pubmed | Substrate specificities and identification of putative substrates of ATM kinase family members. | 5.07e-05 | 25 | 100 | 3 | 10608806 | |
| Pubmed | 7.98e-05 | 29 | 100 | 3 | 39289460 | ||
| Pubmed | SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. | 8.14e-05 | 5 | 100 | 2 | 14654780 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 25133527 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 21778431 | ||
| Pubmed | Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1. | 8.14e-05 | 5 | 100 | 2 | 17046979 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 14630787 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 20477815 | ||
| Pubmed | 8.31e-05 | 486 | 100 | 8 | 20936779 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 38554279 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 22516460 | ||
| Pubmed | Increased enhancer-promoter interactions during developmental enhancer activation in mammals. | 1.22e-04 | 6 | 100 | 2 | 38509385 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 12387869 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 11832213 | ||
| Pubmed | PALB2 is an integral component of the BRCA complex required for homologous recombination repair. | 1.22e-04 | 6 | 100 | 2 | 19369211 | |
| Pubmed | Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis. | 1.70e-04 | 7 | 100 | 2 | 33106502 | |
| Pubmed | Endothelial RAF1/ERK activation regulates arterial morphogenesis. | 1.70e-04 | 7 | 100 | 2 | 23529931 | |
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 1.70e-04 | 7 | 100 | 2 | 22579729 | |
| Pubmed | 1.80e-04 | 407 | 100 | 7 | 12693553 | ||
| Pubmed | 1.81e-04 | 38 | 100 | 3 | 28680062 | ||
| Pubmed | Organization, evolution and functions of the human and mouse Ly6/uPAR family genes. | 1.81e-04 | 38 | 100 | 3 | 27098205 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.91e-04 | 861 | 100 | 10 | 36931259 | |
| Pubmed | 1.96e-04 | 39 | 100 | 3 | 28576773 | ||
| Pubmed | 1.96e-04 | 99 | 100 | 4 | 19730683 | ||
| Pubmed | 2.27e-04 | 8 | 100 | 2 | 18387948 | ||
| Pubmed | c-Raf promotes angiogenesis during normal growth plate maturation. | 2.27e-04 | 8 | 100 | 2 | 26657770 | |
| Pubmed | Slug is a direct Notch target required for initiation of cardiac cushion cellularization. | 2.27e-04 | 8 | 100 | 2 | 18663143 | |
| Pubmed | RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage. | 2.27e-04 | 8 | 100 | 2 | 34408138 | |
| Pubmed | 2.29e-04 | 103 | 100 | 4 | 10819331 | ||
| Pubmed | Confirmed rare copy number variants implicate novel genes in schizophrenia. | 2.91e-04 | 9 | 100 | 2 | 20298200 | |
| Pubmed | Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin. | 2.91e-04 | 9 | 100 | 2 | 15660133 | |
| Pubmed | Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. | 2.91e-04 | 9 | 100 | 2 | 28398198 | |
| Pubmed | Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. | 2.91e-04 | 9 | 100 | 2 | 24085845 | |
| Pubmed | Coordination of Cellular Dynamics Contributes to Tooth Epithelium Deformations. | 2.91e-04 | 9 | 100 | 2 | 27588418 | |
| Pubmed | Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. | 2.91e-04 | 9 | 100 | 2 | 27159393 | |
| Pubmed | The composition and signaling of the IL-35 receptor are unconventional. | 2.91e-04 | 9 | 100 | 2 | 22306691 | |
| Pubmed | 2.91e-04 | 9 | 100 | 2 | 26269593 | ||
| Pubmed | The TFEB-TGIF1 axis regulates EMT in mouse epicardial cells. | 2.91e-04 | 9 | 100 | 2 | 36057632 | |
| Pubmed | Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. | 3.00e-04 | 45 | 100 | 3 | 21258344 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.03e-04 | 588 | 100 | 8 | 38580884 | |
| Pubmed | NRCAM ZNF423 APBB3 ZNF521 ZMYM2 ZNF202 USP9Y TRIM66 USP8 DIP2A ZNF532 ZNF451 | 3.23e-04 | 1285 | 100 | 12 | 35914814 | |
| Pubmed | 3.63e-04 | 10 | 100 | 2 | 21663736 | ||
| Pubmed | 3.63e-04 | 10 | 100 | 2 | 15623520 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.79e-04 | 608 | 100 | 8 | 36089195 | |
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 19584272 | ||
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 24027281 | ||
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 12881723 | ||
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 4.75e-04 | 342 | 100 | 6 | 23455924 | |
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 5.30e-04 | 12 | 100 | 2 | 16391231 | |
| Pubmed | 5.30e-04 | 12 | 100 | 2 | 23740775 | ||
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 5.30e-04 | 12 | 100 | 2 | 16701205 | |
| Pubmed | MRG15 is a novel PALB2-interacting factor involved in homologous recombination. | 5.30e-04 | 12 | 100 | 2 | 19553677 | |
| Pubmed | Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. | 5.30e-04 | 12 | 100 | 2 | 18329369 | |
| Pubmed | Neuronal Ig/Caspr recognition promotes the formation of axoaxonic synapses in mouse spinal cord. | 5.30e-04 | 12 | 100 | 2 | 24411736 | |
| Pubmed | Epithelial-to-mesenchymal transition in epicardium is independent of Snail1. | 5.30e-04 | 12 | 100 | 2 | 23097346 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.44e-04 | 351 | 100 | 6 | 38297188 | |
| Pubmed | 5.46e-04 | 808 | 100 | 9 | 20412781 | ||
| Pubmed | 5.68e-04 | 493 | 100 | 7 | 15368895 | ||
| Pubmed | An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. | 6.25e-04 | 13 | 100 | 2 | 16079794 | |
| Pubmed | Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation. | 6.25e-04 | 13 | 100 | 2 | 26053665 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 SP4 ZNF492 TSHZ3 ZNF142 ZFAT ZNF658 TSHZ2 ZNF423 ZNF521 ZNF202 E4F1 ZNF236 ZNF260 ZIC4 ZSCAN32 ZNF117 ZNF532 ZNF451 ZFP64 ZNF641 SNAI2 ZBTB40 ZFHX2 TSHZ1 ZNF98 ZNF714 | 1.93e-18 | 718 | 80 | 27 | 28 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.67e-07 | 15 | 80 | 4 | 529 | |
| GeneFamily | Slingshot protein phosphatases | 5.78e-05 | 3 | 80 | 2 | 898 | |
| GeneFamily | PATE family|LY6/PLAUR domain containing | 1.15e-04 | 4 | 80 | 2 | 674 | |
| GeneFamily | NLR family | 1.79e-04 | 25 | 80 | 3 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.79e-04 | 25 | 80 | 3 | 994 | |
| GeneFamily | Zinc fingers MYM-type | 2.87e-04 | 6 | 80 | 2 | 86 | |
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 4.52e-04 | 34 | 80 | 3 | 1226 | |
| GeneFamily | Ubiquitin specific peptidases | 1.95e-03 | 56 | 80 | 3 | 366 | |
| GeneFamily | LIM domain containing | 2.27e-03 | 59 | 80 | 3 | 1218 | |
| GeneFamily | PWWP domain containing | 4.22e-03 | 22 | 80 | 2 | 1147 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 5.43e-03 | 25 | 80 | 2 | 504 | |
| GeneFamily | Fibronectin type III domain containing | 5.55e-03 | 160 | 80 | 4 | 555 | |
| Coexpression | GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN | 8.85e-06 | 193 | 99 | 7 | M9712 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_DN | 1.12e-05 | 200 | 99 | 7 | M5963 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.61e-08 | 198 | 100 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.47e-07 | 176 | 100 | 7 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.47e-07 | 176 | 100 | 7 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-07 | 187 | 100 | 7 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-07 | 187 | 100 | 7 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-07 | 187 | 100 | 7 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 2.46e-07 | 190 | 100 | 7 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-07 | 199 | 100 | 7 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-06 | 169 | 100 | 6 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.53e-06 | 172 | 100 | 6 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.62e-06 | 173 | 100 | 6 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 3.09e-06 | 178 | 100 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-06 | 178 | 100 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 3.19e-06 | 179 | 100 | 6 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 181 | 100 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 182 | 100 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 182 | 100 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 182 | 100 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-06 | 183 | 100 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.85e-06 | 185 | 100 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.85e-06 | 185 | 100 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-06 | 187 | 100 | 6 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-06 | 187 | 100 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.10e-06 | 187 | 100 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.10e-06 | 187 | 100 | 6 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.23e-06 | 188 | 100 | 6 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.23e-06 | 188 | 100 | 6 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.49e-06 | 190 | 100 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.49e-06 | 190 | 100 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 4.63e-06 | 191 | 100 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-06 | 191 | 100 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.77e-06 | 192 | 100 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-06 | 193 | 100 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-06 | 193 | 100 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-06 | 193 | 100 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-06 | 194 | 100 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-06 | 194 | 100 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 5.37e-06 | 196 | 100 | 6 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 5.37e-06 | 196 | 100 | 6 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.53e-06 | 197 | 100 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.53e-06 | 197 | 100 | 6 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-06 | 197 | 100 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 198 | 100 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 198 | 100 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 5.69e-06 | 198 | 100 | 6 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-06 | 200 | 100 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-06 | 200 | 100 | 6 | b91f8eb67752a77e1e08e462e50f1b5923695e1b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 160 | 100 | 5 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.55e-05 | 165 | 100 | 5 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.65e-05 | 166 | 100 | 5 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-05 | 167 | 100 | 5 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-05 | 168 | 100 | 5 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 170 | 100 | 5 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 170 | 100 | 5 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.21e-05 | 171 | 100 | 5 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-05 | 172 | 100 | 5 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-05 | 172 | 100 | 5 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-05 | 172 | 100 | 5 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.32e-05 | 172 | 100 | 5 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.96e-05 | 177 | 100 | 5 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.96e-05 | 177 | 100 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.23e-05 | 179 | 100 | 5 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.37e-05 | 180 | 100 | 5 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 180 | 100 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-05 | 180 | 100 | 5 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.37e-05 | 180 | 100 | 5 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 180 | 100 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-05 | 180 | 100 | 5 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 5.51e-05 | 181 | 100 | 5 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 5.66e-05 | 182 | 100 | 5 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-05 | 183 | 100 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-05 | 184 | 100 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.96e-05 | 184 | 100 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 6.11e-05 | 185 | 100 | 5 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.27e-05 | 186 | 100 | 5 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-05 | 186 | 100 | 5 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-05 | 187 | 100 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 187 | 100 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.43e-05 | 187 | 100 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| Disease | interleukin-12 receptor subunit beta-1 measurement | 1.09e-05 | 2 | 98 | 2 | EFO_0801715 | |
| Disease | RNA polymerase II subunit A C-terminal domain phosphatase SSU72 measurement | 1.09e-05 | 2 | 98 | 2 | EFO_0802029 | |
| Disease | Dandy-Walker syndrome (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:2785 (implicated_via_orthology) | |
| Disease | ubiquitin carboxyl-terminal hydrolase 8 measurement | 6.52e-05 | 4 | 98 | 2 | EFO_0802179 | |
| Disease | MASA syndrome (implicated_via_orthology) | 2.27e-04 | 7 | 98 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | sleep latency | 2.54e-04 | 37 | 98 | 3 | EFO_0005280 | |
| Disease | Drug habituation | 5.96e-04 | 115 | 98 | 4 | C0013170 | |
| Disease | Drug abuse | 5.96e-04 | 115 | 98 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.96e-04 | 115 | 98 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.96e-04 | 115 | 98 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.96e-04 | 115 | 98 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.96e-04 | 115 | 98 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.96e-04 | 115 | 98 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.96e-04 | 115 | 98 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.96e-04 | 115 | 98 | 4 | C0029231 | |
| Disease | Substance abuse problem | 6.16e-04 | 116 | 98 | 4 | C0740858 | |
| Disease | Benign tumor of pancreas | 8.32e-04 | 13 | 98 | 2 | C0347284 | |
| Disease | Profound Mental Retardation | 1.21e-03 | 139 | 98 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.21e-03 | 139 | 98 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.21e-03 | 139 | 98 | 4 | C0917816 | |
| Disease | cervical artery dissection | 1.44e-03 | 17 | 98 | 2 | EFO_1000059 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.52e-03 | 68 | 98 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | age at first sexual intercourse measurement | 1.78e-03 | 383 | 98 | 6 | EFO_0009749 | |
| Disease | Pancreatic carcinoma | 1.80e-03 | 19 | 98 | 2 | C0235974 | |
| Disease | cancer (implicated_via_orthology) | 2.03e-03 | 268 | 98 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | osteoarthritis (biomarker_via_orthology) | 2.20e-03 | 21 | 98 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | functional brain measurement | 2.60e-03 | 82 | 98 | 3 | EFO_0007849 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 3.18e-03 | 88 | 98 | 3 | EFO_0803332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSITKSKMHVSFKCE | 71 | Q5JVX7 | |
| VQCHHRLSMTDDSKK | 3571 | Q9NR09 | |
| HSVCANEMRKVSKSS | 196 | Q99708 | |
| KQDRCCHKTVHSMAS | 226 | Q86TB3 | |
| IRKKCASMVHLSQAC | 621 | O43506 | |
| LTSKCAHLCMDSVKT | 361 | Q6ULP2 | |
| VCNFMSHEKCLKHVR | 91 | P52824 | |
| MMTEKHEDHCLKSCS | 976 | Q6DHV5 | |
| TTQCGVISEHTKKMC | 206 | Q14CW9 | |
| KFHEHCSTKVPTMCV | 171 | P04049 | |
| STTKKTCFHNIGEMC | 436 | Q6ZP01 | |
| THMCKYKCREEESSK | 66 | P0C8F1 | |
| MTSCSLKHKQSCAVE | 46 | Q6UY27 | |
| FSSDVTHEMKHKVCR | 146 | Q9H8X2 | |
| LTCTEKTVLHDGKCM | 576 | Q86XX4 | |
| VFQKKLCTAHMCSTL | 231 | O00339 | |
| MLELHCESKCDSHLK | 531 | O00533 | |
| QNHTCMKECHKVTKT | 671 | Q6ZNB6 | |
| SMVSFECKVKHDHTL | 561 | Q92823 | |
| SHLSLMKCDLRASEC | 721 | P59045 | |
| CKRCIHKATNMEFAV | 436 | P51812 | |
| HKACFHCETCKMTLN | 26 | Q14847 | |
| CEDSQLVSHLMSCKK | 1551 | Q5H9U9 | |
| CVADNCHSHAKMLSE | 476 | P16284 | |
| SFCVKHCRNLQKMSL | 641 | Q9NX02 | |
| RHKAFSTCTSHMCSI | 236 | Q8NGI0 | |
| SNHVKSCFHIMDICK | 536 | Q9H422 | |
| SCFHIMDICKSHLNS | 541 | Q9H422 | |
| RLCAKHFETSMICRT | 56 | O43422 | |
| ERKCTDHEFMCANKH | 1261 | Q5VYJ5 | |
| AIHRKLKTCSSMTSH | 416 | Q96NE9 | |
| VASDKDSCMLKCHVF | 216 | O95704 | |
| NECSSKCFHCKRTIM | 96 | Q5TD97 | |
| HSNFTAVCVLKEKCM | 41 | P40189 | |
| NCTMVLLHIVSKCHE | 891 | Q5JSL3 | |
| HCVNSEMEKTCSKEF | 2116 | P51587 | |
| IADKLSILSKCCHAM | 771 | Q9ULE3 | |
| KDHCCMLEFSKILCT | 861 | Q8TF40 | |
| HEKSENMVKAGTCCA | 186 | Q6UXH8 | |
| LHMLSCPCKAKATRT | 286 | P42701 | |
| RGCTTDKCNAHLMTH | 101 | Q6UWN5 | |
| MVTHSSRKDHECKLC | 211 | Q66K89 | |
| RCTMHCNDKAKDSID | 81 | Q96C01 | |
| QLDSCVTKCVDDHMH | 106 | Q96C01 | |
| KMSHAATSALCRSIK | 1166 | Q14689 | |
| HKTCFHCMACRKALD | 31 | P50461 | |
| KNTMTTKECLHRFCS | 56 | Q06587 | |
| ARSLCIILMKHFCSS | 11 | Q5VVW2 | |
| CDVFQHLCKEVSKMH | 186 | Q6T310 | |
| ECSKRFMRSDHLSKH | 711 | Q02446 | |
| CSKTFSRMSLLHKHE | 246 | O43623 | |
| SRMSLLHKHEESGCC | 251 | O43623 | |
| ACDVDCRFKLSTHKM | 1051 | O75182 | |
| VKHCRHFKAMSLCKQ | 631 | Q13018 | |
| HSKCLVHCKMGVSRS | 386 | Q8WYL5 | |
| LMKHASDSHTCVKTK | 211 | Q53FZ2 | |
| SDSHTCVKTKHNEIM | 216 | Q53FZ2 | |
| ADMCTSKSCITHQKF | 141 | Q70EK8 | |
| KCVACHKTLRSHMEL | 316 | Q9Y4E5 | |
| QMKKHPCRQCDKSFS | 1051 | Q9HCE3 | |
| CKKCDESFCMLLHLH | 146 | Q96N38 | |
| HSTEKTHLCDMCGKK | 931 | Q9P243 | |
| KKMHTGEKSHECTEC | 46 | Q3ZCT1 | |
| KMSHQSFCARDKACT | 481 | Q9NX65 | |
| MSLLHSRNSCKTLKC | 441 | Q9C0A1 | |
| SKCLVHCKMGVSRSA | 386 | Q76I76 | |
| TCRMKGKHKDECHNF | 106 | Q9H2E6 | |
| HSKSLDTGNCRICKM | 981 | Q96K83 | |
| ACKMSIHHKCTDGLA | 141 | Q99469 | |
| CKSDQKHKSSCTMTR | 91 | O14798 | |
| KHKSSCTMTRDTVCQ | 96 | O14798 | |
| KEMKRHCTVSTCLDG | 1171 | Q6ZS81 | |
| ECHKAVMRCSTSFIS | 566 | Q8IWV7 | |
| SHSARMTLAKACELC | 2461 | O00507 | |
| KSQILKCMECGSSHD | 376 | Q9NRE2 | |
| RKSQILKCMECGSSH | 381 | Q63HK5 | |
| QHCCSACSMEKDIHK | 796 | Q9BZ95 | |
| LSEKISCKCDSHRMN | 131 | Q5TYW1 | |
| KFHTSLSRMTKGCKC | 536 | Q8NEG5 | |
| HEVSFKNMTHKLCSD | 436 | Q9UBW7 | |
| KNMTHKLCSDHCFNR | 441 | Q9UBW7 | |
| CDKCYTHPSSLRKHM | 271 | Q8N9L1 | |
| CEKSFCMLSHLAQHK | 146 | Q9P255 | |
| ECEKSFCMLSHLAQH | 186 | A6NK75 | |
| MRHTENKHFKCKECR | 101 | Q03924 | |
| CKECRKTFCMLSHLT | 111 | Q03924 | |
| CEEGFRTTVHCKKHM | 1056 | Q9UL36 | |
| REDSQTCHLHKCCMF | 111 | P0C7H9 | |
| TTHCFIHRESLAMKK | 996 | Q6R2W3 | |
| CHQKSHMLAEPFKCT | 386 | Q96LX8 | |
| HSKSLDTGTCRICKM | 981 | Q2M1K9 | |
| MCCLSKLQDKSETHD | 196 | Q504Y3 | |
| TESLFKTHMCPECKR | 156 | P52746 | |
| MARNCSECKEKRAAH | 1 | O15016 | |
| KCMECGKSYTRSSHL | 426 | O95125 | |
| CLTCHKKSRTFEAFM | 936 | P40818 | |
| FCDVRCTMKANLKSH | 446 | Q9NTW7 | |
| RKAQILKCMECGSSH | 411 | Q6ZSZ6 | |
| CKTLCKNFEMLSHVD | 501 | Q14202 | |
| DFLSSFMEKRTICHC | 361 | Q8NEZ2 | |
| DCKKCRMSFPTLQDH | 951 | Q9NUA8 | |
| HHGVTKCNITCSKMT | 26 | P78423 | |
| MSHCIAILKICHTLT | 91 | Q9Y2Y6 | |
| KTKMSSCSQDHRSLV | 726 | Q7Z570 | |
| FKMHTFTRVTSCKVC | 516 | Q9UKW4 | |
| QKTHLHDKTSRCSEC | 311 | Q96N77 | |
| EHMVSSFCLKRCRSA | 646 | P59046 | |
| MTCESQTCLSKKSHG | 956 | Q86UW6 |